ABOUT / EDITORIAL
About TB-500 Medicine
An independent editorial project reading the thymosin beta-4 and TB-500 literature as a console — what it maps, where the human data stop, and how the regulatory status stands.
What this site is
TB-500 Medicine is an independent editorial project that publishes summaries of the peer-reviewed research literature on TB-500 — the synthetic Ac-LKKTETQ fragment of thymosin beta-4 — and on its parent protein. We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The "medicine" in this site's name is editorial framing — a position this publisher occupies relative to the literature, describing what the compound is studied for medicinally. It is not a claim that this site offers treatment, consultation, prescriptions, or any clinical service. There are no "our doctors" here, no pharmacy, no counter. There is a reading of the research and a citation for every number.
How we read the evidence
We hold one distinction harder than any other: TB-500 the heptapeptide (~889 Da) is not the same as full-length thymosin beta-4 (~4963 Da), and most efficacy data are on the protein, not the fragment [5]. Wherever a finding rests on full-length Tβ4, this site flags it at the point of citation. We treat that as the central editorial responsibility of covering this compound honestly, because the marketing rarely makes the distinction and the data demand it.
We lead with what was measured and attribute after. When the literature is precise — the 1:1 actin-sequestration structure [1], the +42% / +61% re-epithelialization figures in rats [3], the IV Phase 1 tolerability to 1260 mg [6] — we say so plainly. When it is incomplete — no completed controlled human trial of the fragment, a tumor/angiogenesis signal that cuts both ways — we say that just as plainly [5][10]. Both are honest sentences, and this console is built to carry both.
Every quantitative claim on this site maps to a numbered source on the references page. We do not write a finding we cannot cite, and we describe doses as study parameters — administered to a given species by a given route — never as recommendations for people.